Dr Reddy's Laboratories Ltd
NSE:DRREDDY

Watchlist Manager
Dr Reddy's Laboratories Ltd Logo
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Watchlist
Price: 1 107.95 INR 0.06% Market Closed
Market Cap: 923.1B INR
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

0
Revenue
+0%
Growth Rates:
1 Year
+15%
3 Years
+50%
5 Years
+83%
7 Years
+118%
10 Years
-
0
Operating Income
+0%
Growth Rates:
1 Year
+8%
3 Years
+101%
5 Years
+138%
7 Years
+412%
10 Years
-
0
Net Income
+0%
Growth Rates:
1 Year
+3%
3 Years
+103%
5 Years
+216%
7 Years
+431%
10 Years
-

Earnings Waterfall
Dr Reddy's Laboratories Ltd

Revenue
312.3B INR
Cost of Revenue
-92.2B INR
Gross Profit
220.1B INR
Operating Expenses
-152.4B INR
Operating Income
67.7B INR
Other Expenses
-14B INR
Net Income
53.7B INR

Income Statement
Dr Reddy's Laboratories Ltd

Rotate your device to view
Income Statement
Currency: INR
Millions
Ones
Thousands
Millions
Billions
TTM
Quarterly
Annual
TTM
Dec-2009 Mar-2010 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024
Revenue
Revenue
73 700
N/A
70 310
-5%
37 728
-46%
77 935
+107%
117 732
+51%
155 683
+32%
150 401
-3%
146 357
-3%
143 792
-2%
141 961
-1%
142 846
+1%
142 281
0%
143 390
+1%
142 810
0%
146 843
+3%
149 420
+2%
149 725
+0%
154 482
+3%
155 699
+1%
165 652
+6%
170 977
+3%
175 170
+2%
180 853
+3%
181 834
+1%
187 282
+3%
190 475
+2%
195 661
+3%
204 421
+4%
208 385
+2%
215 452
+3%
218 330
+1%
223 779
+2%
238 294
+6%
246 697
+4%
261 947
+6%
267 655
+2%
272 125
+2%
280 111
+3%
289 493
+3%
300 849
+4%
312 293
+4%
Gross Profit
Cost of Revenue
(25 251)
(24 108)
(8 852)
(18 133)
(27 936)
(44 636)
(38 720)
(38 113)
(36 469)
(42 082)
(38 993)
(40 688)
(42 896)
(45 203)
(40 852)
(41 000)
(42 391)
(49 796)
(46 968)
(50 462)
(52 857)
(60 126)
(56 671)
(58 461)
(60 685)
(65 647)
(64 614)
(69 089)
(70 859)
(79 972)
(76 514)
(74 708)
(76 575)
(83 048)
(76 840)
(78 400)
(80 146)
(89 398)
(84 528)
(88 165)
(92 220)
Gross Profit
48 449
N/A
46 202
-5%
28 876
-38%
59 802
+107%
89 796
+50%
111 047
+24%
111 681
+1%
108 244
-3%
107 323
-1%
99 879
-7%
103 853
+4%
101 593
-2%
100 494
-1%
97 607
-3%
105 991
+9%
108 420
+2%
107 334
-1%
104 686
-2%
108 731
+4%
115 190
+6%
118 120
+3%
115 044
-3%
124 182
+8%
123 373
-1%
126 597
+3%
124 828
-1%
131 047
+5%
135 332
+3%
137 526
+2%
135 480
-1%
141 816
+5%
149 071
+5%
161 719
+8%
163 649
+1%
185 107
+13%
189 255
+2%
191 979
+1%
190 713
-1%
204 965
+7%
212 684
+4%
220 073
+3%
Operating Income
Operating Expenses
(36 450)
(36 139)
(21 039)
(42 875)
(65 383)
(80 248)
(91 589)
(93 250)
(93 835)
(84 978)
(90 223)
(87 596)
(87 265)
(84 867)
(88 990)
(90 627)
(89 610)
(84 136)
(88 933)
(89 092)
(89 721)
(85 137)
(90 583)
(91 704)
(94 119)
(91 607)
(99 814)
(102 619)
(103 804)
(100 151)
(106 315)
(108 305)
(113 933)
(110 751)
(123 079)
(126 766)
(129 166)
(126 079)
(140 000)
(146 383)
(152 366)
Selling, General & Administrative
(11 571)
(18 743)
(10 632)
(21 496)
(32 391)
(54 026)
(42 687)
(43 189)
(43 585)
(56 054)
(42 493)
(42 045)
(42 292)
(56 703)
(53 562)
(62 709)
(70 013)
(58 399)
(77 482)
(77 296)
(77 959)
(58 810)
(78 919)
(80 006)
(82 178)
(63 851)
(87 610)
(90 639)
(91 994)
(73 399)
(94 551)
(96 390)
(101 723)
(82 048)
(110 062)
(113 086)
(114 988)
(92 026)
(125 027)
(131 195)
(136 199)
Research & Development
(3 872)
(3 731)
0
0
0
(16 927)
0
0
0
(18 658)
0
0
0
(17 392)
0
0
0
(14 389)
0
0
0
(14 696)
0
0
0
(15 468)
0
0
0
(15 100)
0
0
0
(16 201)
0
0
0
(19 353)
0
0
0
Depreciation & Amortization
(4 478)
(4 131)
(2 033)
(4 268)
(6 622)
(9 295)
(9 792)
(10 179)
(10 490)
(10 266)
(10 422)
(10 502)
(10 552)
(10 772)
(10 967)
(11 051)
(11 239)
(11 348)
(11 451)
(11 796)
(11 762)
(11 631)
(11 664)
(11 698)
(11 941)
(12 288)
(12 204)
(11 980)
(11 810)
(11 652)
(11 831)
(11 982)
(12 277)
(12 502)
(13 017)
(13 680)
(14 178)
(14 700)
(14 973)
(15 188)
(16 167)
Other Operating Expenses
(16 529)
(9 534)
(8 374)
(17 111)
(26 370)
0
(39 110)
(39 882)
(39 760)
0
(37 308)
(35 049)
(34 421)
0
(24 461)
(16 867)
(8 358)
0
0
0
0
0
0
0
0
0
0
0
0
0
67
67
67
0
0
0
0
0
0
0
0
Operating Income
11 999
N/A
10 063
-16%
7 837
-22%
16 927
+116%
24 413
+44%
30 799
+26%
20 092
-35%
14 994
-25%
13 488
-10%
14 901
+10%
13 630
-9%
13 997
+3%
13 229
-5%
12 740
-4%
17 001
+33%
17 793
+5%
17 724
0%
20 550
+16%
19 798
-4%
26 098
+32%
28 399
+9%
29 907
+5%
33 599
+12%
31 669
-6%
32 478
+3%
33 221
+2%
31 233
-6%
32 713
+5%
33 722
+3%
35 329
+5%
35 501
+0%
40 766
+15%
47 786
+17%
52 898
+11%
62 028
+17%
62 489
+1%
62 813
+1%
64 634
+3%
64 965
+1%
66 301
+2%
67 707
+2%
Pre-Tax Income
Interest Income Expense
(480)
(312)
(281)
(496)
(656)
(2 287)
(693)
(604)
(608)
997
(701)
(798)
(806)
681
(768)
(753)
(822)
1 112
(829)
(807)
(542)
2 024
(443)
(436)
(497)
2 003
(361)
(169)
(163)
2 813
(481)
(663)
(990)
3 208
(1 133)
(1 275)
(1 284)
4 137
(1 775)
(2 160)
(2 568)
Non-Reccuring Items
(19 211)
(4 583)
0
0
0
(94)
0
(344)
(344)
(374)
0
0
0
0
0
0
0
(116)
0
(3 560)
(16 760)
(16 767)
(16 767)
(13 988)
(6 760)
(6 768)
(8 606)
(7 825)
(1 900)
(9 304)
(7 466)
(7 491)
(7 578)
(699)
(170)
784
808
(3)
987
(866)
(752)
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
460
460
1 257
0
0
0
(67)
0
0
0
(42)
0
0
0
1 119
0
0
0
(1 211)
0
0
0
900
0
0
0
Total Other Income
1 140
1 015
758
1 482
2 100
170
2 862
2 576
2 361
13
1 426
1 281
1 308
83
1 676
2 205
2 798
117
7 435
6 653
6 303
3 760
2 780
2 792
2 824
421
3 122
4 665
4 518
657
12 182
10 535
10 564
6 289
3 580
5 338
6 913
2 342
8 159
9 068
8 408
Pre-Tax Income
(6 553)
N/A
6 183
N/A
8 314
+34%
17 913
+115%
25 857
+44%
28 588
+11%
22 261
-22%
16 622
-25%
14 897
-10%
15 537
+4%
14 355
-8%
14 480
+1%
13 731
-5%
13 504
-2%
17 909
+33%
19 705
+10%
20 160
+2%
22 920
+14%
26 404
+15%
28 384
+7%
17 400
-39%
18 857
+8%
19 169
+2%
20 037
+5%
28 045
+40%
28 835
+3%
25 388
-12%
29 384
+16%
36 177
+23%
30 614
-15%
39 736
+30%
43 147
+9%
49 782
+15%
60 485
+21%
64 305
+6%
67 336
+5%
69 250
+3%
72 010
+4%
72 336
+0%
72 343
+0%
72 795
+1%
Net Income
Tax Provision
(3 540)
(2 668)
(1 888)
(3 797)
(5 948)
(7 511)
(6 149)
(5 196)
(4 430)
(2 965)
(2 676)
(2 843)
(3 113)
(3 111)
(3 406)
(3 090)
(2 446)
(3 855)
(5 251)
(6 226)
(5 540)
1 362
231
1 002
(1 343)
(9 632)
(8 014)
(9 770)
(9 749)
(8 833)
(9 825)
(12 052)
(13 341)
(15 412)
(17 072)
(16 423)
(16 967)
(16 231)
(16 683)
(18 093)
(18 312)
Income from Continuing Operations
(10 092)
3 515
6 426
14 116
19 909
21 077
16 112
11 426
10 467
12 572
11 679
11 637
10 618
10 393
14 503
16 615
17 714
19 065
21 153
22 158
11 860
20 219
19 400
21 039
26 702
19 203
17 374
19 614
26 428
21 781
29 911
31 095
36 441
45 073
47 233
50 913
52 283
55 779
55 653
54 250
54 483
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(862)
(767)
Equity Earnings Affiliates
0
0
49
106
170
229
253
281
306
349
374
381
377
344
329
346
350
438
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Income (Common)
(10 093)
N/A
3 515
N/A
6 475
+84%
14 222
+120%
20 079
+41%
21 306
+6%
16 365
-23%
11 707
-28%
10 773
-8%
12 921
+20%
12 053
-7%
12 018
0%
10 122
-16%
9 468
-6%
13 563
+43%
15 692
+16%
17 668
+13%
19 500
+10%
21 505
+10%
27 390
+27%
17 003
-38%
20 260
+19%
19 441
-4%
16 091
-17%
21 754
+35%
19 516
-10%
17 374
-11%
19 614
+13%
26 428
+35%
21 825
-17%
29 911
+37%
31 095
+4%
36 441
+17%
45 073
+24%
47 233
+5%
50 913
+8%
52 283
+3%
55 779
+7%
55 653
0%
53 388
-4%
53 716
+1%
EPS (Diluted)
-59.72
N/A
20.57
N/A
37.85
+84%
83.16
+120%
117.42
+41%
124.59
+6%
96.26
-23%
70.52
-27%
64.89
-8%
77.37
+19%
72.6
-6%
71.53
-1%
60.97
-15%
57.03
-6%
81.7
+43%
94.53
+16%
106.43
+13%
117.46
+10%
129.54
+10%
163.03
+26%
102.42
-37%
122.04
+19%
117.11
-4%
96.93
-17%
130.26
+34%
117.56
-10%
104.54
-11%
117.95
+13%
158.93
+35%
26.24
-83%
179.83
+585%
186.93
+4%
219.01
+17%
54.18
-75%
283.59
+423%
305.4
+8%
62.7
-79%
66.92
+7%
66.73
0%
64.08
-4%
64.36
+0%

See Also

Summary
DRREDDY intrinsic value, competitors valuation, and company profile.
DCF Valuation
DRREDDY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DRREDDY stock valuation using valuation multiples.
Wall Street Estimates
DRREDDY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DRREDDY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 238,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.